Home
Browse All Titles
Sign In
Browse All Titles
Clinical Anesthesia
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Medication Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002?IndexTerms-page=3
◀
*
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
▶
View All
Primidone
Pristiq
Probenecid
Procainamide
Atlas of Electrocardiography
Drugs with Significant Renal Excretion Encountered in Anesthesiology
Examples of Genetic Polymorphisms Involved in Variable Responses to Drugs Used in the Perioperative Period
Medications for Pediatric Resuscitation
Myasthenia Gravis
Pharmacologic Principles
Systemic Lupus Erythematosus
Procaine
Agents Implicated in Allergic Reactions
Antimuscarinic Compounds Associated with Central Anticholinergic Syndrome
Antimuscarinic Compounds Associated with Central Anticholinergic Syndrome - Table
Cholinesterase Disorders
Clinical Profile of Local Anesthetics
Local Anesthetics
Pharmacokinetic Parameters of Clinically Used Local Anesthetics
Physicochemical Properties of Clinically Used Local Anesthetics
Regional Anesthesia
Relative Potency for Systemic Central Nervous System Toxicity by Local Anesthetics and Ratio of Dosage Needed for Cardiovascular System: Central Nervous System (CVS:CNS) Toxicity
Specific Procedures
The Incidence of Transient Neurologic Symptoms (TNSs) Varies with Type of Spinal Local Anesthetic and Surgery
Transient Neurologic Symptoms after Spinal Anesthesia
Procyclidine
Antimuscarinic Compounds Associated with Central Anticholinergic Syndrome
Antimuscarinic Compounds Associated with Central Anticholinergic Syndrome - Table
Progesterone
Acid-Base Disorders
Altered Drug Responses
Anesthetic Dose Requirements of Neonates
Gastrointestinal Changes
Respiratory Changes
Promethazine
Antiemetics
Antimuscarinic Compounds Associated with Central Anticholinergic Syndrome
Antimuscarinic Compounds Associated with Central Anticholinergic Syndrome - Table
Nausea and Vomiting
Persistent Sedation/Delayed Emergence
Postoperative Nausea and Vomiting
Propafenone
Propantheline Bromide
Antimuscarinic Compounds Associated with Central Anticholinergic Syndrome
Antimuscarinic Compounds Associated with Central Anticholinergic Syndrome - Table
Propofol Injection
General Anesthesia
Opioids
Propofol
Propoxyphene
Classification of Exogenous Opioids
Opioid Analgesic Pharmacokinetics
Propranolol
Propylthiouracil
-Adrenoceptor Antagonists (-Blockers)
Causes of Hypothyroidism
Hyperthyroidism
Management of Thyroid Storm
Prostacyclin
Algorithm for the Diagnosis and Treatment of Hemodynamic Abnormalities on Termination of Cardiopulmonary Bypass
Comparison of the Balance in the Biologic Actions of Prostacyclin and Thromboxane in Normal Pregnancy with the Imbalance of Increased Thromboxane and Decreased Prostacyclin in Preeclamptic Pregnancy
Hypertensive Disorders of Pregnancy
IgE-mediated Pathophysiology
Intraoperative Management
Lung Recipient Selection Guidelines
Norepinephrine
Other Determinants of Hypoxic Pulmonary Vasoconstriction
Overview of Platelet Pathways for Adherence, Activation, Stabilization, and Physiologic Inhibition
Recipient Selection
The Pulmonary System
Vasopressors
Prostaglandin E
Hypertensive Disorders of Pregnancy
Mineralocorticoid Physiology
Prostaglandin E1
Anesthesiology Setup for Organ Procurement
Brain-dead Donors (Donation after Neurologic Death)
Medications Given by Continuous Infusion
Pheochromocytoma
Prostaglandin I2 (PGI2)
Protamine
Protriptyline
Prozac
Methadone Drug Interactions
Monoamine Oxidase Inhibitors
Selective Serotonin Reuptake Inhibitors
Serotonergic Psychiatric Drugs Implicated in the Cases of Serotonin Syndrome with Methylene Blue
Pseudo
Agents Implicated in Allergic Reactions
Aortic Stenosis
Left Ventricular Walls
Pharmacodynamic Interactions
Systemic Sclerosis (Scleroderma)
This is a Simulation of a Target-Controlled Infusion (TCI) in Which the Effect Site Concentration (C (e)) is Targeted at 5 g/mL
This is a Simulation of a Target-Controlled Infusion (TCI) in Which the Plasma Concentration is Targeted at 5 g/mL
PTU
Pyridostigmine
Anticholinesterase Agents
Anticholinesterase Drugs Used to Treat Myasthenia Gravis
Cholinergic Drugs
Cholinesterase Disorders
Cholinesterase Inhibitors
Drug Shortages and Clinical Impact
Drugs with Significant Renal Excretion Encountered in Anesthesiology
Myasthenia Gravis
Myasthenia Gravis
Nerve Agents
Orthostatic Hypotension
Selective Relaxant Binding Agents
Refresh
first
prev
1
2
3
30
select
next
last
Displaying items 61 - 85 of 85